Magnus Gisslén

Magnus Gisslén

UNVERIFIED PROFILE

Are you Magnus Gisslén?   Register this Author

Register author
Magnus Gisslén

Magnus Gisslén

Publications by authors named "Magnus Gisslén"

Are you Magnus Gisslén?   Register this Author

100Publications

1670Reads

32Profile Views

Lower risk of multiple sclerosis in patients with chronic hepatitis C: a nationwide population-based registry study.

J Neurol 2019 Sep 31;266(9):2208-2215. Epub 2019 May 31.

Department of Infectious Diseases, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00415-019-09397-8DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6687702PMC
September 2019

Serum-based diagnosis of Pneumocystis pneumonia by detection of Pneumocystis jirovecii DNA and 1,3-β-D-glucan in HIV-infected patients: a retrospective case control study.

BMC Infect Dis 2019 Jul 23;19(1):658. Epub 2019 Jul 23.

Department of Infectious Diseases, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12879-019-4289-4DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6651925PMC
July 2019

Diagnostic Value of Cerebrospinal Fluid Neurofilament Light Protein in Neurology: A Systematic Review and Meta-analysis.

JAMA Neurol 2019 Jun 17. Epub 2019 Jun 17.

UCL Institute of Neurology, Queen Square, London, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaneurol.2019.1534DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6580449PMC
June 2019

Cerebrospinal Fluid Concentrations of the Synaptic Marker Neurogranin in Neuro-HIV and Other Neurological Disorders.

Curr HIV/AIDS Rep 2019 Feb;16(1):76-81

Department of Infectious Diseases, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, 416 45, Gothenburg, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11904-019-00420-1DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6420419PMC
February 2019

CSF concentrations of soluble TREM2 as a marker of microglial activation in HIV-1 infection.

Neurol Neuroimmunol Neuroinflamm 2019 Jan 7;6(1):e512. Epub 2018 Nov 7.

Department of Infectious Diseases (M.G., A.Y., L.-M.A., L.H.), Institute of Biomedicine, the Sahlgrenska Academy at University of Gothenburg, Sweden; Department of Molecular Neuroscience (A.H., E.V., H.Z.), UCL Institute of Neurology, Queen Square; UK Dementia Research Institute at UCL (A.H., E.V., H.Z.), London, United Kingdom; Department of Neurology and Center for Neuroepidemiology and Clinical Neurological Research (S.S.), Yale University, New Haven, CT; Division of Biological Chemistry (D.F.), Biocenter, Medical University of Innsbruck, Austria; Department of Neurology (R.W.P.), University of California San Francisco; Clinical Neurochemistry Laboratory (H.Z.), Sahlgrenska University Hospital; and Department of Psychiatry and Neurochemistry (H.Z.), Institute of Neuroscience and Physiology, the Sahlgrenska Academy at University of Gothenburg, Mölndal, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1212/NXI.0000000000000512DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6278890PMC
January 2019

Antiretroviral treatment of acute HIV infection normalizes CSF markers of CNS inflammation. A consequence of reduced CNS reservoir?

J Infect Dis 2019 Jan 21. Epub 2019 Jan 21.

Department of Medicine, Division of Experimental Medicine, University of California San Francisco, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/infdis/jiz031DOI Listing
January 2019

Persistent central nervous system immune activation following more than 10 years of effective HIV antiretroviral treatment.

AIDS 2018 09;32(15):2171-2178

Department of Infectious Diseases, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/QAD.0000000000001950DOI Listing
September 2018

Prophylaxis and treatment of HIV-1 infection in pregnancy - Swedish Recommendations 2017.

Infect Dis (Lond) 2018 07 24;50(7):495-506. Epub 2018 Jan 24.

b Department of Clinical Science , Intervention and Technology (CLINTEC), Karolinska Institutet , Stockholm , Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/23744235.2018.1428825DOI Listing
July 2018

Effect of dolutegravir in combination with Nucleoside Reverse Transcriptase Inhibitors (NRTIs) on people living with HIV who have pre-existing NRTI mutations.

Int J Antimicrob Agents 2018 May 31;51(5):733-738. Epub 2018 Jan 31.

Department of Infectious Diseases, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, 413 90 Gothenburg, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijantimicag.2018.01.009DOI Listing
May 2018

Effect of therapy switch on time to second-line antiretroviral treatment failure in HIV-infected patients.

PLoS One 2017 20;12(7):e0180140. Epub 2017 Jul 20.

Unit of Infectious Diseases, Department of Medicine Huddinge, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0180140PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5519043PMC
September 2017

Neurofilament light chain protein as a marker of neuronal injury: review of its use in HIV-1 infection and reference values for HIV-negative controls.

Expert Rev Mol Diagn 2017 08 14;17(8):761-770. Epub 2017 Jun 14.

a Institute of Biomedicine, Department of Infectious Diseases , University of Gothenburg , Gothenburg , Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/14737159.2017.1341313DOI Listing
August 2017

No support for premature central nervous system aging in HIV-1 when measured by cerebrospinal fluid phosphorylated tau (p-tau).

Virulence 2017 07 19;8(5):599-604. Epub 2016 Jul 19.

a Department of Infectious Diseases , Institute of Biomedicine, University of Gothenburg , Gothenburg , Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/21505594.2016.1212155DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5538341PMC
July 2017

Association between Plasma Homocysteine Levels and Neuronal Injury in HIV Infection.

PLoS One 2016 21;11(7):e0158973. Epub 2016 Jul 21.

Department of Infectious Diseases, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0158973PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4956037PMC
July 2017

Recent increased identification and transmission of HIV-1 unique recombinant forms in Sweden.

Sci Rep 2017 07 25;7(1):6371. Epub 2017 Jul 25.

Division of Clinical Microbiology, Department of Laboratory Medicine, Karolinska Institutet, Huddinge, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41598-017-06860-2DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5527090PMC
July 2017

Ex vivo O-labeling mass spectrometry identifies a peripheral amyloid β clearance pathway.

Mol Neurodegener 2017 02 20;12(1):18. Epub 2017 Feb 20.

Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry, The Sahlgrenska Academy at University of Gothenburg, Mölndal, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13024-017-0152-5DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5317049PMC
February 2017

HIV-1 low copy viral sequencing-A prototype assay.

Infect Dis (Lond) 2016 14;48(6):472-6. Epub 2016 Jan 14.

b Department of Clinical Virology , University of Gothenburg , Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/23744235.2015.1133925DOI Listing
January 2017

Antiretroviral treatment for HIV infection: Swedish recommendations 2016.

Infect Dis (Lond) 2017 Jan 2;49(1):1-34. Epub 2016 Nov 2.

l Division of Infectious Diseases, Department of Medicine Huddinge , Karolinska Institutet , Stockholm , Sweden ; All members of the Swedish Reference Group for Antiviral Therapy.

View Article

Download full-text PDF

Source
https://www.tandfonline.com/doi/full/10.1080/23744235.2016.1
Publisher Site
http://dx.doi.org/10.1080/23744235.2016.1247495DOI Listing
January 2017

Immediate initiation of cART is associated with lower levels of cerebrospinal fluid YKL-40, a marker of microglial activation, in HIV-1 infection.

AIDS 2017 01;31(2):247-252

aDepartment of Medicine, Brigham and Women's Hospital, Boston, Massachusetts bDepartment of Neurology, Memory and Aging Center, University of California, San Francisco, California, USA cSEARCH, The Thai Red Cross AIDS Research Center, Bangkok, Thailand dUS Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring eHenry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, Maryland , USA fDepartment of Infectious Diseases, Institute of Biomedicine, Gothenburg gDepartment of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, the Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden hUniversity College London Institute of Neurology, London, UK iYale University School of Medicine, New Haven, Connecticut, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/QAD.0000000000001314DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5844231PMC
January 2017

Asymptomatic Cerebrospinal Fluid HIV-1 Viral Blips and Viral Escape During Antiretroviral Therapy: A Longitudinal Study.

J Infect Dis 2016 Dec 28;214(12):1822-1825. Epub 2016 Sep 28.

Department of Infectious Diseases, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/infdis/jiw454DOI Listing
December 2016

Blood-brain barrier integrity, intrathecal immunoactivation, and neuronal injury in HIV.

Neurol Neuroimmunol Neuroinflamm 2016 Dec 9;3(6):e300. Epub 2016 Nov 9.

Department of Infectious Diseases, Institute of Biomedicine (B.A., A.Y., L.H., M.G.), and Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology (H.Z.), Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden; Department of Molecular Neuroscience (H.Z.), UCL Institute of Neurology, Queen Square, London, UK; Mathematical Sciences (S.N.), Chalmers University of Technology, Gothenburg, Sweden; Departments of Neurology and HIV Medicine (B.J.B.), St Vincent's Hospital and Peter Duncan Neurosciences Unit, St Vincent's Centre for Applied Medical Research, University of New South Wales, Sydney, Australia; Division of Biological Chemistry (D.F.), Biocenter, Innsbruck Medical University, Innsbruck, Austria; and Department of Neurology (R.W.P.), University of California San Francisco.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1212/NXI.0000000000000300DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5104266PMC
December 2016

Cerebrospinal fluid analysis for HIV replication and biomarkers of immune activation and neurodegeneration in long-term atazanavir/ritonavir monotherapy treated patients.

Medicine (Baltimore) 2016 Jul;95(28):e4144

aDepartment of Infectious Diseases, IRCCS San Raffaele Scientific Institute bNeuroradiology Unit, Head and Neck Department, IRCCS San Raffaele Scientific Institute, Milan, Italy cDepartment of Infectious Diseases, University of Gothenburg, Sahlgrenska University Hospital, Gothenburg dClinical Neurochemistry Laboratory, Institute of Neuroscience and Physiology, The Sahlgrenska Academy, University of Gothenburg, Mölndal, Sweden eDepartment of Molecular Neuroscience, Institute of Neurology, University College London, London, UK fDivision of Biological Chemistry, Innsbruck Medical University, Innsbruck, Austria gUnit of Clinical Pharmacology, L. Sacco University Hospital, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MD.0000000000004144DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4956796PMC
July 2016

Viral blips during suppressive antiretroviral treatment are associated with high baseline HIV-1 RNA levels.

BMC Infect Dis 2016 06 21;16:305. Epub 2016 Jun 21.

Department of Infectious Diseases, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, 413 90, Gothenburg, Sweden.

View Article

Download full-text PDF

Source
http://bmcinfectdis.biomedcentral.com/articles/10.1186/s1287
Publisher Site
http://dx.doi.org/10.1186/s12879-016-1628-6DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4915053PMC
June 2016

Soluble CD14 in cerebrospinal fluid is associated with markers of inflammation and axonal damage in untreated HIV-infected patients: a retrospective cross-sectional study.

BMC Infect Dis 2016 Apr 21;16:176. Epub 2016 Apr 21.

Department of Infectious Diseases, Viro-immunology Research Unit, Rigshospitalet, University of Copenhagen, Blegdamsvej 9, DK 2100, Copenhagen Ø, Denmark.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12879-016-1510-6DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4839160PMC
April 2016

Reduced Baseline Sensitivity to Maraviroc Inhibition Among R5 HIV-1 Isolates From Individuals With Severe Immunodeficiency.

J Acquir Immune Defic Syndr 2016 Mar;71(3):e79-82

Departments of *Clinical Sciences †Laboratory Medicine ‡Experimental Medical Science, Lund University, Lund, Sweden §Department of Neuroscience, CNS and Pain, AstraZeneca R&D, Södertälje, Sweden ‖Department of Infectious Diseases, University of Gothenburg, Gothenburg, Sweden ¶Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom **Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/QAI.0000000000000873DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4770368PMC
March 2016

Plasma Concentration of the Neurofilament Light Protein (NFL) is a Biomarker of CNS Injury in HIV Infection: A Cross-Sectional Study.

EBioMedicine 2016 Jan 22;3:135-140. Epub 2015 Nov 22.

Clinical Neurochemistry Laboratory, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Mölndal, Sweden; UCL Institute of Neurology, Queen Square, London, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ebiom.2015.11.036DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4739412PMC
January 2016

The cerebrospinal fluid biomarker profile in an HIV-infected subject with Alzheimer's disease.

AIDS Res Ther 2015 14;12:23. Epub 2015 Jul 14.

Department of Infectious Diseases, University of Gothenburg, Sahlgrenska University Hospital, Gothenburg, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12981-015-0063-xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4501274PMC
July 2015

Cerebrospinal Fluid HIV Escape from Antiretroviral Therapy.

Curr HIV/AIDS Rep 2015 Jun;12(2):280-8

Department of Infectious Diseases, San Raffaele Scientific Institute, Via Stamira d'Ancona, 20, 20127, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11904-015-0267-7DOI Listing
June 2015

Temporal trends in the Swedish HIV-1 epidemic: increase in non-B subtypes and recombinant forms over three decades.

PLoS One 2014 12;9(6):e99390. Epub 2014 Jun 12.

Division of Clinical Microbiology, Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden; Unit of Infectious Diseases, Department of Medicine Huddinge, Karolinska Institutet, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0099390PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4055746PMC
January 2015

Biomarker evidence of axonal injury in neuroasymptomatic HIV-1 patients.

PLoS One 2014 11;9(2):e88591. Epub 2014 Feb 11.

Institute of Biomedicine, Department of Infectious Diseases, University of Gothenburg, Gothenburg, Sweden.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0088591PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3921217PMC
October 2014

Low levels of HIV-1 RNA detected in the cerebrospinal fluid after up to 10 years of suppressive therapy are associated with local immune activation.

AIDS 2014 Sep;28(15):2251-8

aDepartment of Microbiology, Tumor and Cell Biology, Karolinska Institutet and Swedish Institute for Communicable Disease Control, Stockholm, Sweden bDepartment of Neurology, University of California San Francisco, San Francisco, USA cDivision of Biological Chemistry, Biocentre, Innsbruck Medical University, Innsbruck, Austria dDepartment of Infectious Diseases, University of Gothenburg, Gothenburg, Sweden eCentre for Virus Research, Westmead Millennium Institute, Westmead fThe University of Sydney, Sydney, New South Wales, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/QAD.0000000000000400DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4492794PMC
September 2014

An example of genetically distinct HIV type 1 variants in cerebrospinal fluid and plasma during suppressive therapy.

J Infect Dis 2014 May 12;209(10):1618-22. Epub 2013 Dec 12.

Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet and Swedish Institute for Communicable Disease Control, Stockholm.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/infdis/jit805DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3997583PMC
May 2014

Evolving character of chronic central nervous system HIV infection.

Semin Neurol 2014 Feb 8;34(1):7-13. Epub 2014 Apr 8.

UNC Center for AIDS Research and the Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1055/s-0034-1372337DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4120280PMC
February 2014

Treatment of HIV in the Central Nervous System.

Semin Neurol 2014 Feb 8;34(1):14-20. Epub 2014 Apr 8.

Department of Infectious Diseases, University of Gothenburg, Gothenburg, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1055/s-0034-1372338DOI Listing
February 2014

Approach to cerebrospinal fluid (CSF) biomarker discovery and evaluation in HIV infection.

J Neuroimmune Pharmacol 2013 Dec 13;8(5):1147-58. Epub 2013 Aug 13.

Department of Neurology, University of California San Francisco, San Francisco General Hospital, Bldg 1 Room 101, Potrero Avenue, Box 0870 1001, San Francisco, CA, 94110, USA,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11481-013-9491-3DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3889225PMC
December 2013

Lopinavir/ritonavir, atazanavir/ritonavir, and efavirenz in antiretroviral-naïve HIV-1-infected individuals over 144 weeks: an open-label randomized controlled trial.

Scand J Infect Dis 2013 Jul 7;45(7):543-51. Epub 2013 Jan 7.

Department of Infectious Diseases, Institute of Biomedicine at Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/00365548.2012.756985DOI Listing
July 2013

Cerebrospinal fluid neopterin decay characteristics after initiation of antiretroviral therapy.

J Neuroinflammation 2013 May 10;10:62. Epub 2013 May 10.

Department of Infectious Diseases, University of Gothenburg, Journalvagen 10, Gothenburg, 416 50, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1742-2094-10-62DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3657550PMC
May 2013

Cerebrospinal fluid Alzheimer's biomarker profiles in CNS infections.

J Neurol 2013 Feb 9;260(2):620-6. Epub 2012 Oct 9.

Department of Infectious Diseases, University of Gothenburg, Gothenburg, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00415-012-6688-yDOI Listing
February 2013

Cerebrospinal fluid viral breakthrough in two HIV-infected subjects on darunavir/ritonavir monotherapy.

Scand J Infect Dis 2012 Dec 9;44(12):997-1000. Epub 2012 Jul 9.

Department of Infectious Diseases, University of Gothenburg, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/00365548.2012.690526DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3507278PMC
December 2012

Cerebrospinal fluid markers in central nervous system HIV infection and AIDS dementia complex.

Handb Clin Neurol 2007 ;85:261-300

Clinic of Infectious Diseases, San Raffaele Scientific Institute, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S0072-9752(07)85017-2DOI Listing
October 2012

Antiretroviral drug treatment of CNS HIV-1 infection.

J Antimicrob Chemother 2012 Feb 8;67(2):299-311. Epub 2011 Dec 8.

Institute of Biomedicine, Department of Infectious Diseases, University of Gothenburg, Smörslottsgatan 1, 416 85 Gothenburg, Sweden.

View Article

Download full-text PDF

Source
https://academic.oup.com/jac/article-lookup/doi/10.1093/jac/
Publisher Site
http://dx.doi.org/10.1093/jac/dkr492DOI Listing
February 2012

Bilirubin-a potential marker of drug exposure in atazanavir-based antiretroviral therapy.

AAPS J 2011 Dec 13;13(4):598-605. Epub 2011 Sep 13.

Unit for Pharmacokinetics and Drug Metabolism, Department of Pharmacology, Sahlgrenska Academy at University of Gothenburg, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1208/s12248-011-9299-0DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3231858PMC
December 2011

The definition of HIV-associated neurocognitive disorders: are we overestimating the real prevalence?

BMC Infect Dis 2011 Dec 28;11:356. Epub 2011 Dec 28.

Department of Infectious Diseases, Sahlgrenska University Hospital, University of Gothenburg, Sweden.

View Article

Download full-text PDF

Source
http://bmcinfectdis.biomedcentral.com/articles/10.1186/1471-
Publisher Site
http://dx.doi.org/10.1186/1471-2334-11-356DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3260107PMC
December 2011

Lyme neuroborreliosis in HIV-1 positive men successfully treated with oral doxycycline: a case series and literature review.

J Med Case Rep 2011 Sep 19;5:465. Epub 2011 Sep 19.

Institute of Biomedicine, the Sahlgrenska Academy, University of Gothenburg, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1752-1947-5-465DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3183041PMC
September 2011

Treatment intensification has no effect on the HIV-1 central nervous system infection in patients on suppressive antiretroviral therapy.

J Acquir Immune Defic Syndr 2010 Dec;55(5):590-6

Department of Infectious Diseases, Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/QAI.0b013e3181f5b3d1DOI Listing
December 2010

HIV-1 viral escape in cerebrospinal fluid of subjects on suppressive antiretroviral treatment.

J Infect Dis 2010 Dec 4;202(12):1819-25. Epub 2010 Nov 4.

Department of Infectious Diseases, The Sahlgrenska Academy at University of Gothenburg, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1086/657342DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3052942PMC
December 2010

Cerebrospinal fluid neopterin: an informative biomarker of central nervous system immune activation in HIV-1 infection.

AIDS Res Ther 2010 Jun 3;7:15. Epub 2010 Jun 3.

Department of Infectious Diseases, Sahlgrenska University Hospital, University of Gothenburg; SE 41685 Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1742-6405-7-15DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2890504PMC
June 2010

The relation between treatment outcome and efavirenz, atazanavir or lopinavir exposure in the NORTHIV trial of treatment-naïve HIV-1 infected patients.

Eur J Clin Pharmacol 2010 Apr 5;66(4):349-57. Epub 2009 Dec 5.

Department of Clinical Pharmacology, Karolinska University Hospital and Karolinska Institutet, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00228-009-0763-zDOI Listing
April 2010

Treatment of HIV infection: Swedish recommendations 2009.

Scand J Infect Dis 2009 ;41(11-12):788-807

Department of Clinical Pharmacology, Karolinska University Hospital, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/00365540903214322DOI Listing
March 2010

Amyloid and tau cerebrospinal fluid biomarkers in HIV infection.

BMC Neurol 2009 Dec 22;9:63. Epub 2009 Dec 22.

Department of Infectious Diseases, University of Gothenburg, Sahlgrenska University Hospital, SE-416 85 Gothenburg, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1471-2377-9-63DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2807422PMC
December 2009

Cerebrospinal fluid maraviroc concentrations in HIV-1 infected patients.

AIDS 2009 Nov;23(18):2537-40

Department of Infectious Diseases, the Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/QAD.0b013e328333ae0eDOI Listing
November 2009

Raltegravir cerebrospinal fluid concentrations in HIV-1 infection.

PLoS One 2009 Sep 1;4(9):e6877. Epub 2009 Sep 1.

Department of Infectious Diseases, the Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0006877PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2731205PMC
September 2009

Darunavir concentrations in cerebrospinal fluid and blood in HIV-1-infected individuals.

AIDS Res Hum Retroviruses 2009 Apr;25(4):457-61

Department of Infectious Diseases, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.

View Article

Download full-text PDF

Source
http://www.liebertpub.com/doi/10.1089/aid.2008.0216
Publisher Site
http://dx.doi.org/10.1089/aid.2008.0216DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2853865PMC
April 2009

Once-daily fosamprenavir with ritonavir in the treatment of HIV infection in therapy-naïve patients.

Ther Clin Risk Manag 2008 Dec;4(6):1281-4

Department of Infectious Diseases, Malmö University Hospital, Malmö, Sweden.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2643108PMC
December 2008

Persistent intrathecal immune activation in HIV-1-infected individuals on antiretroviral therapy.

J Acquir Immune Defic Syndr 2008 Feb;47(2):168-73

Department of Infectious Diseases, The Sahlgrenska Academy at Göteborg University, Göteborg, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/QAI.0b013e31815ace97DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2628632PMC
February 2008

Immune activation of the central nervous system is still present after >4 years of effective highly active antiretroviral therapy.

J Infect Dis 2007 Dec;196(12):1779-83

Department of Infectious Diseases, The Sahlgrenska Academy at Göteborg University, Göteborg, Sweden.

View Article

Download full-text PDF

Source
https://academic.oup.com/jid/article-lookup/doi/10.1086/5236
Publisher Site
http://dx.doi.org/10.1086/523648DOI Listing
December 2007

Antiretroviral treatment of HIV infection: Swedish recommendations 2007.

Scand J Infect Dis 2007 ;39(6-7):486-507

Department of Clinical Pharmacology, Karolinska University Hospital, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/00365540701383154DOI Listing
November 2007

Defining and evaluating HIV-related neurodegenerative disease and its treatment targets: a combinatorial approach to use of cerebrospinal fluid molecular biomarkers.

J Neuroimmune Pharmacol 2007 Mar 12;2(1):112-9. Epub 2006 Sep 12.

Department of Infectious Diseases, The Sahlgrenska Academy at Göteborg University, Göteborg, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11481-006-9035-1DOI Listing
March 2007